HEADER HYDROLASE 04-SEP-03 1UN5 TITLE ARH-II, AN ANGIOGENIN/RNASE A CHIMERA COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOGENIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RIBONUCLEASE 5, RNASE 5; COMPND 5 EC: 3.1.27.5; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: RESIDUES 38-42 IN THE COORDINATES ARE FROM COMPND 9 BOVINE PANCREATIC RIBONUCLEASE A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: W3110; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PANG3; SOURCE 9 OTHER_DETAILS: GUEST SEGMENT IS BOVINE. SYNTHETIC GENE KEYWDS HYDROLASE, PANCREATIC RIBONUCLEASE, ANGIOGENESIS, KEYWDS 2 ANGIOGENIN, CHIMERA, HYBRID, HOMOLOG SCANNING MUTAGENESIS EXPDTA X-RAY DIFFRACTION AUTHOR D.E.HOLLOWAY,M.D.BAKER,K.R.ACHARYA REVDAT 2 24-FEB-09 1UN5 1 VERSN REVDAT 1 06-FEB-04 1UN5 0 JRNL AUTH D.E.HOLLOWAY,G.B.CHAVALI,M.C.HARES,M.D.BAKER, JRNL AUTH 2 G.V.SUBBARAO,R.SHAPIRO,K.R.ACHARYA JRNL TITL CRYSTALLOGRAPHIC STUDIES ON STRUCTURAL FEATURES JRNL TITL 2 THAT DETERMINE THE ENZYMATIC SPECIFICITY AND JRNL TITL 3 POTENCY OF HUMAN ANGIOGENIN: THR44, THR80 AND JRNL TITL 4 RESIDUES 38-41 JRNL REF BIOCHEMISTRY V. 43 1230 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 14756559 JRNL DOI 10.1021/BI035654+ REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.D.LEONIDAS,R.SHAPIRO,S.C.ALLEN,G.V.SUBBARAO, REMARK 1 AUTH 2 K.VELURAJA,K.R.ACHARYA REMARK 1 TITL REFINED CRYSTAL STRUCTURES OF NATIVE HUMAN REMARK 1 TITL 2 ANGIOGENIN AND TWO ACTIVE SITE VARIANTS: REMARK 1 TITL 3 IMPLICATIONS FOR THE UNIQUE FUNCTIONAL PROPERTIES REMARK 1 TITL 4 OF AN ENZYME INVOLVED IN NEOVASCULARISATION DURING REMARK 1 TITL 5 TUMOUR GROWTH REMARK 1 REF J.MOL.BIOL. V. 285 1209 1999 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9918722 REMARK 1 DOI 10.1006/JMBI.1998.2378 REMARK 1 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.W.HARPER,E.A.FOX,R.SHAPIRO,B.L.VALLEE REMARK 1 TITL MUTAGENESIS OF RESIDUES FLANKING LYS-40 ENHANCES REMARK 1 TITL 2 THE ENZYMATIC ACTIVITY AND REDUCES THE ANGIOGENIC REMARK 1 TITL 3 POTENCY OF ANGIOGENIN REMARK 1 REF BIOCHEMISTRY V. 29 7297 1990 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 1698454 REMARK 1 DOI 10.1021/BI00483A020 REMARK 2 REMARK 2 RESOLUTION. 2.6 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.19 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 5503 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 259 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 546 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1260 REMARK 3 BIN FREE R VALUE SET COUNT : 27 REMARK 3 BIN FREE R VALUE : 0.2350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 923 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 13 REMARK 3 SOLVENT ATOMS : 9 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.55000 REMARK 3 B22 (A**2) : 4.13000 REMARK 3 B33 (A**2) : -3.58000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.469 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.273 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.120 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.954 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1034 ; 0.010 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): 1395 ; 1.342 ; 1.936 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 122 ; 5.697 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 140 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 811 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 337 ; 0.196 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 30 ; 0.129 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 20 ; 0.270 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.173 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 613 ; 0.835 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 992 ; 1.560 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 421 ; 1.751 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 403 ; 2.982 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UN5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-SEP-03. REMARK 100 THE PDBE ID CODE IS EBI-13445. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 5.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : RH/SI MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5767 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2ANG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.2 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 6000, PH 5.4 REMARK 280 0.2M SODIUM POTASSIUM TARTRATE, 0.02M SODIUM CITRATE BUFFER REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.68300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 18.68300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 40.13500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 61.98650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 40.13500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 61.98650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 18.68300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 40.13500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 61.98650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 18.68300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 40.13500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 61.98650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 REPLACEMENT OF ANGIOGENIN 62-65 WITH RIBONUCLEASE A 64-68. REMARK 400 (RESIDUE NUMBERING BASED ON SWISSPROT SEQUENCE DATABASE). REMARK 400 THE RESIDUE NUMBERS REPLACED IN THE COORDINATES ARE 38-41 REMARK 400 OF ANGIOGENIN WITH RESIDUES 38-42 OF BOVINE REMARK 400 RIBONUCLEASE. REMARK 400 REMARK 400 ANGIOGENIC RIBONUCLEASE THAT BINDS TO ACTIN ON THE SURFACE REMARK 400 OF ENDOTHELIAL CELLS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLN A 1 REMARK 465 ASP A 2 REMARK 465 PRO A 124 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 3 N CB CG OD1 ND2 REMARK 470 SER A 4 OG REMARK 470 LYS A 17 CD CE NZ REMARK 470 GLN A 19 CG CD OE1 NE2 REMARK 470 ARG A 24 CD NE CZ NH1 NH2 REMARK 470 ARG A 39 CD NE CZ NH1 NH2 REMARK 470 ARG A 52 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 60 CG OD1 ND2 REMARK 470 LYS A 61 CG CD CE NZ REMARK 470 ASN A 69 CG OD1 ND2 REMARK 470 LYS A 83 CD CE NZ REMARK 470 ARG A 96 CD NE CZ NH1 NH2 REMARK 470 ARG A 123 C O CB CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 15 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 38 -60.66 -107.74 REMARK 500 ARG A 67 -127.58 42.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN A 50 24.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A1124 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A4Y RELATED DB: PDB REMARK 900 RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX REMARK 900 RELATED ID: 1ANG RELATED DB: PDB REMARK 900 ANGIOGENIN REMARK 900 RELATED ID: 1AWZ RELATED DB: PDB REMARK 900 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN REMARK 900 DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1B1E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT REMARK 900 K40Q REMARK 900 RELATED ID: 1B1I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REMARK 900 RELATED ID: 1B1J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT REMARK 900 H13A. REMARK 900 RELATED ID: 1GV7 RELATED DB: PDB REMARK 900 GUEST-HOST CROSSTALK IN AN ANGIOGENIN/RNASE REMARK 900 A CHIMERIC PROTEIN REMARK 900 RELATED ID: 1H0D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN REMARK 900 COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL REMARK 900 ANTIBODY MAB 26-2F REMARK 900 RELATED ID: 1H52 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS REMARK 900 AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REMARK 900 REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1H53 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS REMARK 900 AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REMARK 900 REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1HBY RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS REMARK 900 AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REMARK 900 REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1K58 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT REMARK 900 D116H REMARK 900 RELATED ID: 1K59 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT REMARK 900 Q117G REMARK 900 RELATED ID: 1K5A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN DOUBLE REMARK 900 VARIANTI119A/F120A REMARK 900 RELATED ID: 1K5B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT REMARK 900 DES(121-123) REMARK 900 RELATED ID: 1UN3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT REMARK 900 T44D REMARK 900 RELATED ID: 1UN4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT REMARK 900 T80A REMARK 900 RELATED ID: 2ANG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE REMARK 900 MET(-1) FORM DBREF 1UN5 A 0 0 PDB 1UN5 1UN5 0 0 DBREF 1UN5 A 1 37 UNP P03950 ANGI_HUMAN 25 61 DBREF 1UN5 A 38 42 UNP P00656 RNP_BOVIN 64 68 DBREF 1UN5 A 43 124 UNP P03950 ANGI_HUMAN 66 147 SEQRES 1 A 125 MET GLN ASP ASN SER ARG TYR THR HIS PHE LEU THR GLN SEQRES 2 A 125 HIS TYR ASP ALA LYS PRO GLN GLY ARG ASP ASP ARG TYR SEQRES 3 A 125 CYS GLU SER ILE MET ARG ARG ARG GLY LEU THR SER ASP SEQRES 4 A 125 ARG CYS LYS PRO ILE ASN THR PHE ILE HIS GLY ASN LYS SEQRES 5 A 125 ARG SER ILE LYS ALA ILE CYS GLU ASN LYS ASN GLY ASN SEQRES 6 A 125 PRO HIS ARG GLU ASN LEU ARG ILE SER LYS SER SER PHE SEQRES 7 A 125 GLN VAL THR THR CYS LYS LEU HIS GLY GLY SER PRO TRP SEQRES 8 A 125 PRO PRO CYS GLN TYR ARG ALA THR ALA GLY PHE ARG ASN SEQRES 9 A 125 VAL VAL VAL ALA CYS GLU ASN GLY LEU PRO VAL HIS LEU SEQRES 10 A 125 ASP GLN SER ILE PHE ARG ARG PRO HET CIT A1124 13 HETNAM CIT CITRIC ACID FORMUL 2 CIT C6 H8 O7 FORMUL 3 HOH *9(H2 O1) HELIX 1 1 SER A 4 TYR A 14 1 11 HELIX 2 2 ASP A 22 ARG A 33 1 12 HELIX 3 3 ASN A 50 ALA A 56 1 7 HELIX 4 4 ILE A 57 GLU A 59 5 3 HELIX 5 5 GLN A 118 ARG A 122 5 5 SHEET 1 AA 3 ILE A 43 ILE A 47 0 SHEET 2 AA 3 PHE A 77 LEU A 84 -1 O THR A 80 N PHE A 46 SHEET 3 AA 3 TYR A 95 ARG A 102 -1 O ARG A 96 N LYS A 83 SHEET 1 AB 4 GLY A 63 HIS A 66 0 SHEET 2 AB 4 LEU A 70 SER A 73 -1 O LEU A 70 N HIS A 66 SHEET 3 AB 4 VAL A 105 GLU A 109 -1 O VAL A 106 N ARG A 71 SHEET 4 AB 4 LEU A 112 LEU A 116 -1 O LEU A 112 N GLU A 109 SSBOND 1 CYS A 26 CYS A 82 1555 1555 2.02 SSBOND 2 CYS A 40 CYS A 93 1555 1555 2.02 SSBOND 3 CYS A 58 CYS A 108 1555 1555 2.03 CISPEP 1 PRO A 91 PRO A 92 0 1.19 SITE 1 AC1 5 HIS A 66 ARG A 67 GLY A 100 PHE A 101 SITE 2 AC1 5 ARG A 102 CRYST1 80.270 123.973 37.366 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012458 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008066 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026762 0.00000 MASTER 436 0 1 5 7 0 2 6 0 0 0 10 END